Address: Küçükbakkalköy Mahallesi Sehit Sakir Elkovan, Caddesi, No:2 ,TR-34750 Atasehir – Istanbul
TURKEY
Tel: +90 216 570 9500
Web: http://www.novartis.com.tr/Default.aspx?sayfa=anasayfa
Novartis, the pharmaceutical industry is the leading company in Turkey. With approximately 2300 employees in Turkey, manufacturing, marketing, clinical research activities conducted Novartis manufacturing facility is located at 3. Novartis Turkey, especially in many European countries including Switzerland, Middle East, South and Central American countries also engaged in production. Novartis, the country has exported more than 90 in 2011. Turkey’s R & D activities in the international drug companies, 1/3 ‘reputation Novartis conducts itself. Health activities in the field ”First Health, First Human” combines the principle of Novartis, health, culture , art, education and environmental issues to support social responsibility projects.
Alzheimer’s,Diabetes, Epilepsy, Hepatitis B, Bone Metastases, Leukemia, Breast Cancer ,Organ Transplant, Osteoporosis, Parkinson
Novartis country president Peter Catalino discusses the need for Turkey to introduce financial investment incentives to compete more effectively with other countries for investments in R&D and manufacturing. You arrived…
Gamze Çıtıroğlu, Murat Çıtıroğlu and Pınar Çakır of Ekin Kimya discuss the progress of the Turkish pharma industry moving towards biotechnology. Moreover, they give insights into Ekin Kimya’s partnership strategy…
Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish market. She provides her expert insights into current trends in the Turkish generics…
Uğur Bingöl, general manager of Ibrahim Etem Menarini, speaks of his company’s rapid growth and new product lines. He also describes his take on the Turkish pharmaceutical market and outlines…
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares the company’s plans to become Turkey’s leading biotech entity and gives insights into the group’s international expansion plans. He…
The Minister of Health of the Republic of Turkey, Dr Fahrettin Koca, provides an overview of the current state of the Turkish healthcare ecosystem, highlighting its opportunities and challenges. He…
Handan Boyce, general manager of the Istanbul Lütfi Kırdar International Convention and Exhibition Center, offers her insights into the Turkish congress sector, underlining the industry’s strong suits and highlighting the…
Levent Canyurt, CEO and founder of BIEM Ilac, shares how he transformed the company from a domestic pharmaceutical distributor into an international player, with an innovative portfolio for the treatment…
Mehmet Baharoglu and Beril Tezcanli of Birgi Mefar Group, Turkey’s leading CMO with a proven track record and experience of production across all small and medium volume injectable dosage forms…
* Dr Fabrizio Guidi has left his role as country chair & general manager Rx of Sanofi Turkey and is currently Sanofi’s general manager of diabetics and cardiovascular for Germany, Switzerland…
Barış Özyurtlu, general manager of Berko Pharmaceuticals, one of the fastest growing companies in Turkey, provides insights into the company’s innovative vision and proprietary technologies, such as its spoon-shaped product…
Şekib Avdagiç, president of the Istanbul Chamber of Commerce and Istanbul Convention and Visitors Bureau (ICVB) provides an in-depth analysis of the ICVB’s services, the main trends shaping the city’s…
Mahmut Oguzcan, country business leader of 3M Turkey, offers his expert insights into the Turkish medical devices market. He explains how Turkey’s Health Transformation Program (HTP) and private-public partnership (PPP)…
See our Cookie Privacy Policy Here
